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Controlled Clinical Studies of Air Pollutant
Exposure: Evaluating Scientific Information in
Relation to Air Quality Standards
by Jack D. Hackney* and William S. Linn*
In controlled clinical studies, volunteers are deliberately exposed to specific air pollu-
tants under conditions simulating ambient exposures, and health-related responses are
documented. Studies ofthe health risks ofair pollution need to be scientifically rigorous
and clearly relevant to "real-world" pollution exposures. Their results should be con-
firmed by independent replication if they are to be used as a basis for air quality
regulations. Well-designed controlled clinical studies readily meet these criteria, and
complement the other methods of scientific risk assessment-animal toxicology and
epidemiology. Clinical studies, toxicology, and epidemiology all have provided important
information about air pollution health effects. A better understanding of the interrela-
tionships offindings from these different fields is needed.
Introduction
This paper focuses on clinical studies ofhuman
volunteers deliberately exposed to specific airpol-
lutants. Most such investigations are performed
for the express purpose of guiding air quality
regulatory decisions. They establish atmospheric
conditions in a controlled laboratory setting
which are considered relevant to actual ambient
polluted atmospheres and attempt to document
any health-related effects which result from
breathing the laboratory atmospheres.
Clinical studies to some extent combine the
strong point of animal toxicology-rigorous con-
trol of the experimental subject and environ-
ment-with the strong point of epidemiology-
unquestioned relevance to human health.
However, clinical studies are limited by ethical
and practical considerations to small groups of
people, short durations of exposure, and atmo-
spheres expected to produce only mild and tempo-
rary health effects, at most. Regulatory agencies
must consider large and diverse populations at
risk of long-term as well as short-term effects,
and must try to protect the most susceptible
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groups of people. Clinical studies thus often in-
vestigate a group likely to be at especially high
risk from air pollution, e.g., asthmatics or people
who exercise heavily outdoors, and a concentra-
tion of pollutants equal to the worst likely to
occur in ambient episodes. Such "worst-case" ex-
perimental conditions are assumed to produce
responses comparable to the most severe effects
likely to occur in the most reactive members of
relevant community populations. Tb the extent
that this assumption is valid, prediction of re-
sponses in large populations from data on small
experimental groups is not too serious a problem.
Prediction of long-term effects from short-term
observations clearly is a serious problem, which
cannot be addressed by clinical studies alone. It
may be partly resolvable, however, ifappropriate
links can be established between clinical-study
findings and observations from animal toxicology
and epidemiology. More will be said about this
later.
We have reviewed past findings from human
exposure studies and suggested means of apply-
ingthemto regulatorydecisions, in greaterdetail
elsewhere (1-3). Here we wish to mention only a
few recent experimental studies while presenting
opinions on some more general scientific and pol-
icy questions. One important general questionHACKNEY AND LINN
concerns the proper definition of"adverse health
effects" from which the law requires people to be
protected. Before addressing this, we wish to dis-
cuss a related issue: maximizing the effectiveness
and efficiency of the scientific air pollution risk
assessment process. How can we avoid wrong
conclusions from scientific studies which result
either in unrealistic expectations ofhealth bene-
fit and socioeconomically harmful overregulation
of air quality or, conversely, in failure to recog-
nize and control genuine pollution-related health
hazards? Mistakes may, ofcourse, be made either
in the choice of problems to be studied, in the
scientific investigation itself, orinthe subsequent
policymaking process. Mistakes inthe second and
third categories mentioned are unlikely if both
scientists and policymakers pay attention to rea-
sonable criteria for the design, conduct, and eval-
uation of risk-assessment studies. Experiments
should be scientifically rigorous in traditional
terms: they should address a clearly formulated
hypothesis usingadesign andmeasurement tech-
niques adequate to support the hypothesis and
rule out alternative possibilities. Experiments
should be clearly relevant to human health and
ambient air pollution problems: they should ap-
proach as closely as practical the situation ofthe
real person at risk in the real polluted environ-
ment being evaluated. Finally, experimental
results should be independently replicated before
being considered fully acceptable as bases for
regulatory policy decisions: we need reasonable
assurance that the observations are independent
ofany specific observer. Tb restate the point more
concisely: Scientific risk-assessment data should
be given credence to the extent that they are
scientifically rigorous, relevant to human health
concerns, and redundant (independently repli-
cated). "Unconfirmed" findings-data which fail
to meet one or more ofthe above criteria-are not
excluded from consideration, since federal air
quality standards are required to incorporate a
"margin ofsafety," i.e., to be set somewhat below
the lowest exposure level known to produce an
adverse effect. A decision on the magnitude of a
"margin of safety" may reasonably take into ac-
count "unconfirmed" as well as "confirmed" find-
ings.
Recent Studies of Sulfur Dioxide
In reviewing the clinical studies ofsulfur-con-
taining pollutants in 1978 (4) and again in 1980
(2), we concluded that no physiological or clinical
effects of sulfur dioxide (SO2) had been demon-
strated at exposure concentrations below 0.75
ppm-a level only infrequently reached in am-
bientpollution. Thistendedtoplaceclinical study
results at odds with a large body ofepidemiologic
data: many epidemiologic studies suggested asso-
ciations between commonly occurring elevated
levels of sulfur oxides and increased respiratory
morbidity or mortality. The positive epidemio-
logic findings might have reflected effects ofpar-
ticulate pollutants coexisting with SO2, but clini-
cal studies of particulate pollutants generally
have not shown effects at concentrations relevant
to ambient exposures. The situation changed
somewhat with publication of a recent study by
Sheppard et al. (5) which indicated that young
adult asthmatic volunteers developed significant
increases in airway resistance while exercising
during exposure to SO2 concentrations of0.25 and
0.50 ppm (in comparison to similar control experi-
ments in which S02-free filtered air was
breathed). Some subjects also developedwheezing
and shortness of breath in 0.50 ppm exposures.
The SO2 was administered by mouthpiece with
the nose occluded during the exercise-exposure
period, which lasted 10 min.
How should this new finding be applied to air
quality policy decisions? From one viewpoint, it
tends to support the epidemiologic data associat-
ing ambient SO2 with respiratory morbidity, in
that the exposure concentrations examined are
more or less in the same range. On the other
hand, the conditions under which SO2 was
breathed in the laboratory exposure were unlike
those typical of ambient SO2 exposures, and the
volunteer subject population may or may not
have been comparable to epidemiologic study pop-
ulations apparently affected by S02-containing
pollution. By our previously stated criteria, inde-
pendent replication ofthe findings ofSheppard et
al. shouldbe sought, andtheirdegreeofrelevance
to ambient exposures judged, before they are
given the most serious consideration by air qual-
ity regulators. Some discussion of the relevance
issue has already appeared in the literature. The
application ofSheppard and co-workers' and simi-
lar data to air qualty standards has been chal-
lenged on the grounds that the experimental ex-
posure procedure, involving breathing through a
mouthpiece with the nose occluded, unrealisti-
cally bypasses much ofthe nasal and oral pollu-
tant scrubbing capability (6). Thus, an unrealisti-
cally high dose to the lungs would occur at any
given exposure concentration. Sheppard et al.
have counter-argued that their findings have im-
portant implications for air quality standards (7).
They contend that the quantitative reduction in
SO2 dose by upper-airway scrubbing is relatively
188CLINICAL STUDIES AND AIR QUALITY REGULATION
unimportant during exercise, particularly in peo-
ple with nasal obstruction.
More than most other fields of investigation,
clinical studies provide the means to resolve con-
troversies like that described above through fur-
ther experimental work. We have initiated a
study which should be able to provide at least
indirect confirmation of Sheppard and co-work-
ers'findingswith low-level SO2, while atthe same
time testing their applicability to more realistic
exposure conditions. Twenty-four young adult
nonsmoking asthmatic volunteers were recruited
and exposed on three separate occasions to clean
air, 0.25 ppm SO2, and 0.5 ppm SO2, in random
order. Exposures took place in a large controlled-
environment chamber allowing freedom of move-
ment and unobstructed breathing. Exposures
lasted 1 hr and included intermittent exercise.
Airway resistance measurements were taken be-
fore exposure, after an initial 10-min exercise
period, and nearthe end ofthe hour. Ifsignificant
increases occurred within 10 min and were still
present at 1 hr, itwouldbe reasonable to conclude
that the responses observed by Sheppard et al.
can occur in ambient exposures, and persist long
enough to be of health concern. If no significant
response oronly a transient response (reversedby
the end of the hour) were found, there might be
less cause for concern. Only preliminary results,
requiring verification by more extensive data
analysis, are currently available from this study.
They are discussed here not to suggest any defini-
tive conclusions about effects of SO2, but as an
illustration of a (hopefully) logical and orderly
means ofprogress in scientific risk assessment.
We initially performed pilot studies, primarily
to test the operation of our airway resistance
measuring equipment, in which five asthmatic
volunteers were exposed to clean air and to 0.5
ppm SO2 by mouth during 10 min of moderate
exercise under a protocol similar to that ofShep-
pard et al. All five showed increased resistance
after exercise even when clean air was breathed.
Four of the five showed greater increases in re-
sistance after SO2 than after clean air. The fifth
subject did not show any excess effect at 0.5 ppm
SO2, but didwhenreexposed at 1.0 ppm. Only one
person showed even a slight excess ofrespiratory
symptoms with 0.5 ppm SO2 as compared to clean
air. The resistance data certainly tend to support
the findings of Sheppard et al.; but they do not
provide independent confirmation in the strict
sense, because the number of subjects was small
and the design did not control completely for
time-dependent effects.
In the main study, no statistically significant
variation in airway resistance attributable to SO2
was found for the group (Table 1). A small but
significant increase attributable to exercise was
observed, even though the exercise level was only
mild to moderate (ranging from 300 kg-m/min for
the least fit subjects to 500 kg-m/min for the most
fit subjects) and the relative humidity was kept
high (above 90% at an exposure temperature near
75 F) to minimize bronchoconstriction due to air-
way cooling (8). Forced expiratory tests and
symptom interviews also failed to detect a signifi-
cant effect ofSO2.
The contrastbetweenthe lack ofdetectable SO2
effect at 0.5 ppm with unencumbered breathing
and the apparent effect with mouthpiece breath-
ing (assuming that it stands up to further scru-
tiny) raises a new series of questions. Are there
subgroups ofasthmatics who react to 0.5 ppm or
less, even with unencumbered breathing, whose
responses are masked by those ofthe unreactive
majority? Would other pollutants coexisting in
ambient airincrease theresponse? Ibwhatactual
extent does the nose scrub out inhaled SO2? What
concentration ofSO2 would produce a measurable
effect in people with complete nasal obstruction,
or in people who breathe through tracheostomies
Table 1. Preliminary statistical results from a study of24 asthmatic volunteers exposed to SO2: mean specific airway
resistance and results ofrepeated-measures analyses ofvariance.a
Specific airway resistancea
Exposure Exposure Exposure
SO2, ppm 0 min -15 min -55 min Significanceb
All subjects 0.0 5.40 7.23 7.57 p (SO2 level) = 0.184
0.25 4.37 5.14 4.75 p (exp. time) = 0.054
0.50 5.42 6.68 6.51 p (interaction) = 0.179
23 subjectsc 0.0 4.44 5.02 5.21 p (SO2 level) = 0.164
0.25 4.18 4.54 4.39 p (exp. time) < 0.001
0.50 4.33 5.13 4.90 p (interaction) = 0.153
aSpecific airway resistance = [resistance in cmH20/(Lsec)] x (lung volume in L).
bp values should be considered approximate, since adjustments for nonideal distribution ofdata have not been applied. cExcluding one subject who hadmarkedly greaterresistance than all others on some occasions, not attributableto S02 exposure.
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andthus are without upper-airway defense mech-
anisms? How would higher levels of exercise,
lower air temperature, or lower humidity affect
the response? Most if not all of these questions
can be addressed directly in further clinical stud-
ies, the results of which might raise more ques-
tions requiring still further investigation. A par-
ticularly attractive feature of clinical studies is
that each "increment" ofresearch should require
a reasonably small time and resource commit-
ment, and should add meaningfully to the data
base supporting regulatory decisions.
Proper Evaluation of "Adverse
Health Effects"
The investigations just described were con-
ducted on the premise that increases in airway
resistance with pollutant exposure relate in a
meaningful waytohealth riskfromthepollutant.
Is this really true? Asthmatic attacks certainly
involve increased airway resistance, and cer-
tainly reflect an undesirable state of health. In-
creased resistance implies increased work of
breathing and therefore less availability ofmeta-
bolic energy for productive use. On the other
hand, at least some people seem able to incur
substantial increases in resistance without any
obvious effectontheirperformance capabilities or
clinical status. Some asthmatics in particular,
evenwhen symptom-free, seemto showwide vari-
ations in resistance over short periods oftime in
response to a variety of stimuli. How, then,
should we apply experimental findings like those
described to decisions on air quality policy to
protect health? At one time, it was usually as-
sumed (at least implicitly) that any detectable
physiological change, under any exposure condi-
tion relatable to ambient exposures, should be
considered evidence ofhealth risk. While not un-
reasonable, this assumption no longer seems via-
ble as a strict basis for policy decisions, given the
increasing costs of pollution control efforts and
the increasing number ofrecognized problems to
be dealt with. Ultimately, broadly based political
decisions should determine which effects are
truly "adverse" and must be prevented by control
efforts, and which will be tolerated in order to
address other social needs. The needed scientific
input to this political process is information from
which to set priorities for health protection-to
rate the levels ofrelative "adversity" ofdifferent
possible effects.
Possible clinical effects of pollution can be
prioritized roughly on the basis of their severity
and duration. Problems which result in substan-
tial permanent disability ordecreased life expect-
ancy clearly belong at the top of the prevention
priority list. Of less concern, but still clearly
within most people's definition of"adversity," are
temporary disabling illnesses (e.g., viral respira-
tory infections) and temporary exacerbations of
chronic conditions (e.g., asthma episodes). At a
still lower level of concern are slight and tran-
sient clinical effects which do not prevent usual
activities but do perceptibly impair performance
capability and one's sense ofwell-being.
Physiological effects, at least those of short
duration, might be prioritized according to their
tendency to produce impairment of performance
or clinical status, as illustrated by the following
example. The effects most often reported in clini-
cal studies are increased airway resistance, as
discussed earlier, and reduced forced expiratory
performance, asdetectedby decreases inthe max-
imal forced expired volume in one second (FEV1)
andrelated measures. Resistance effects are often
found in SO2 exposures, whereas ozone exposures
are more likely to produce forced expiratory ef-
fects. Which is more important to health? We
would argue that reduced FEV1 is ofgreater con-
cern, since it seems more closely related to per-
formance capability. The FEV1 may be viewed as
a very rough estimate ofthe maximum volume of
breath a person can take during exercise, since a
typical breathing pattern and typical exercise
respiration rate of 30/min would allow slightly
more than 1 sec for expiration. Any decrease in
FEV1 with exposure, regardless of its cause (in-
creased resistance, coughing, pain on deep
breathing, etc.) thus implies a corresponding de-
crease in the ability to ventilate the lungs. If
impaired oxygenation were shown directly, e.g., if
arterial blood oxygen content were shown to de-
crease withexposure, thiswouldbe cause foreven
greater concern, by our reasoning. (Such effects
have been suggestd in a few clinical studies but
not confirmed, to the best of our knowledge.)
Resistance changes, if not clinically perceptible,
seem of less concern since their relationship to
physical performance is more tenuous.
Most likely, there will be substantial disagree-
ment concerning the health significance of the
milder physiological and clinical effects likely to
result from air pollution, and the point at which
they should be legally defined as "adverse." There
would be much less room for disagreement ifthe
long-term consequences of short-term, ap-
parently fully reversible effects were understood.
This would require the demonstration of links
between clinical studies, which are limited to
short-term effects, and animal toxicology andepi-CLINICAL STUDIES AND AIR QUALITYREGULATION 191
demiology, which can address both short- and
long-term effects. Furthermore, linksbetween ob-
served short- and long-term effects would have to
be demonstrated.
Animal toxicologists need to develop tests of
short-term respiratory physiological response to
pollutants which have counterparts in human
studies. They could then relate physiological to
pathological changes, both in the short term and
in the long term, and possibly could relate this
information to human health risks. Epidemiolo-
gists need to investigate exposed populations lon-
gitudinally, to better understand the ambient ex-
posure circumstances (if any) which are
associated with the development of chronic dis-
ease in the longterm, and to identify any associa-
tions between long-term effects and short-term,
apparently reversible effects. Ofparticular inter-
est wouldbe longitudinal studies of"panels" iden-
tifiedby clinical studies as havingatypically high
or atypically low short-term sensitivity to expo-
sure. This would test the common (but largely
unsupported) belief that people unusually sensi-
tive to short-term effects are at increased risk to
develop chronic illness in the long term.
The aforementioned links across scientific dis-
ciplines and between short- and long-term inves-
tigations now exist only very tenuously, ifat all.
To establish them firmly would require the solv-
ing of many difficult problems, conceptual and
experimental, relating to "basic science" as well
as to highly "applied" empirical investigations. A
large and long-term commitment of resources
would be required-not a likely prospect at
present, particularly in light of other unmet
needs in health care and environmental protec-
tion. We should always keep in mind, though,
that the known costs ofair pollution control, and
the suspected costs of ill health from inadequate
control, are orders of magnitude larger than re-
search budgets. Well-planned risk assessment re-
search is likely to be a very sound investment,
paying off in greater cost effectiveness ofregula-
tory policy.
This work was supported by Contract RP-1225 from the
Electric Power Research Institute.
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